Thoraxklinik Heidelberg

Heidelberg 69126

1 studies enrolling now · 8 studies all time

What they study most

COPD, Carcinoma, Non-small-cell Lung, Chronic Bronchitis, Chronic Thromboembolic Pulmonary Hypertension, Hypertension, Pulmonary, Metastatic Non-small Cell Lung Cancer, Non-small Cell Lung Cancer, Sarcoidosis-associated Pulmonary Hypertension

Studies at this site

• LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC — Recruiting now
• A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) — Completed
• A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension — Stopped early
• Evaluation of the Safety and Efficacy of TLD in Patients with COPD — Running, not enrolling
• A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag — Stopped early
• Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis — Status unconfirmed
• OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed